Enhanced adherence to HCV therapy with higher dose ribavirin formulation: final analyses from the ADHERE registry.

scientific article published on 25 May 2010

Enhanced adherence to HCV therapy with higher dose ribavirin formulation: final analyses from the ADHERE registry. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1365-2036.2010.04381.X
P698PubMed publication ID20500732
P5875ResearchGate publication ID44628670

P2093author name stringI Alam
B Cecil
K D Kistler
T Stainbrook
P2860cites workImpact of fixed-dose and multi-pill combination dyslipidemia therapies on medication adherence and the economic burden of sub-optimal adherenceQ43270283
Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin doseQ29547886
The prevalence of hepatitis C virus infection in the United States, 1999 through 2002Q29619974
Antiviral therapy for cirrhotic hepatitis C: association with reduced hepatocellular carcinoma development and improved survivalQ42990049
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectribavirinQ421862
P304page(s)535-542
P577publication date2010-05-25
P1433published inAlimentary Pharmacology & TherapeuticsQ4726656
P1476titleEnhanced adherence to HCV therapy with higher dose ribavirin formulation: final analyses from the ADHERE registry.
P478volume32

Reverse relations

cites work (P2860)
Q93048181A Randomized Controlled Trial to Assess the  Impact of Clinical Pharmacy Interventions on Treatment Outcomes, Health Related Quality of Life and Medication Adherence Among Hepatitis C Patients
Q34506193Adherence during antiviral treatment regimens for chronic hepatitis C: a qualitative study of patient-reported facilitators and barriers
Q36990416Adherence to PEG/ribavirin treatment for chronic hepatitis C: prevalence, patterns, and predictors of missed doses and nonpersistence
Q36496953Anemia management in the era of triple combination therapy for chronic HCV.
Q36418455Chronic hepatitis C and antiviral treatment regimens: where can psychology contribute?
Q36079814Evidence-based interventions to enhance assessment, treatment, and adherence in the chronic Hepatitis C care continuum.
Q36285092Health state utilities associated with attributes of treatments for hepatitis C.
Q36120739Once-daily dose regimen of ribavirin is interchangeable with a twice-daily dose regimen: randomized open clinical trial
Q33774344Self-efficacy and adherence to antiviral treatment for chronic hepatitis C.

Search more.